RELATED CONTENT
April 19, 2022 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...
September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
May 25, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
January 18, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
November 17, 2020 — Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging ...
November 3, 2020 — The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded the 20 ...
January 17, 2020 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading ...
December 10, 2019 — Bracco Diagnostics Inc., the U.S subsidiary of Bracco Imaging S.p.A., a leading global company in ...
Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium sulfate) for oral suspension, which is indicated for modified barium swallow (MBS) studies. The contrast agent is used to detect and assess the type and severity of swallowing disorders also known as dysphagia.
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are now ...